This switch in splicing resulted in a decrease in the ratio of hnRNPB1 to hnRNPA2 and an increase in the ratio of Bcl-xs to Bcl-xl in all 3-cancer cell lines (Figure 3B). The gene discussed is HNRNPA2B1; the disease is cancer.